• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

Fungal Theory Debated in Amphotericin B Controversy

by Sue Pondrom • March 1, 2008

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

Dr. Bhattacharyya further said that the real reason amphotericin B is controversial is because there’s a lot more to be learned about the pathophysiology and the mechanism of action of amphotericin B. Also, the underlying evidence for fungi as the cause-complete for CRS is actually weak. If you look at detailed studies, you can find people who have evidence of an allergic sensitivity to the fungus, but no symptoms.

You Might Also Like

  • The Etiology of Chronic Rhinosinusitis Remains Unclear
  • Is Topical Amphotericin B Efficacious in the Treatment of Chronic Rhinosinusitis?
  • Report May Change Diagnosis, Management of Chronic Rhinosinusitis
  • Early Diagnosis, Treatment Essential in Acute Invasive Fungal Sinusitis in Patients with Recent COVID-19 Infection
Explore This Issue
March 2008
Figure. SinuNase(TM) interim, blinded data for CS (Graphic: Business Wire).

click for large version
Figure. SinuNase(TM) interim, blinded data for CS (Graphic: Business Wire).

Another component, he said, is that there is evidence that amphotericin B as a chemical agent alone is an anti-inflammatory, meaning that it may be working on the inflammation in chronic rhinosinusitis but not killing fungus.

On the plus side, Dr. Bhattacharyya said amphotericin B is a relatively low-toxicity agent when applied topically. I see little downside in trying this as one modality of therapy for patients who are medically refractory, he said, adding that it might be a good choice for patients who have already had surgery (surgery that allows the drug to reach the surface of the sinus cavities more directly). I do have a subset of patients who have benefited from it. But, I’ve also had patients who have not.

About Amphotericin B

An antifungal treatment-specifically, amphotericin B-was chosen by the Mayo Clinic and later tested by others for efficacy in treating CRS. Originally extracted from the filamentous bacterium Streptomyces nodosus, amphotericin B is used to kill fungus that can cause serious or life-threatening infections, but it is not effective against bacterial infections or viruses. Although administration of the drug can cause side effects-some potentially severe-the small amount used as a lavage to kill noninvasive fungus in the nose and sinus cavities is considered much safer. It has low systemic absorption, with less than 5% systemic absorption across mucous membranes. As its mechanism of action, amphotericin B binds to sterols-preferentially to the primary fungal cell membrane sterol, ergosterol-disrupting osmotic integrity of the fungal membrane. The result is leakage of intracellular potassium, magnesium, sugars, and metabolites, followed by cellular death.

©2008 The Triological Society

Pages: 1 2 3 4 5 6 | Single Page

Filed Under: Allergy, Departments, Medical Education, Practice Focus, Rhinology Tagged With: allergic sinusitis, CT, debate, fungus, medication, research, rhinosinusitis, Sinusitis, treatmentIssue: March 2008

You Might Also Like:

  • The Etiology of Chronic Rhinosinusitis Remains Unclear
  • Is Topical Amphotericin B Efficacious in the Treatment of Chronic Rhinosinusitis?
  • Report May Change Diagnosis, Management of Chronic Rhinosinusitis
  • Early Diagnosis, Treatment Essential in Acute Invasive Fungal Sinusitis in Patients with Recent COVID-19 Infection

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Would you choose a concierge physician as your PCP?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Popular this Week
  • Most Popular
  • Most Recent
    • A Journey Through Pay Inequity: A Physician’s Firsthand Account

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • Excitement Around Gene Therapy for Hearing Restoration
    • “Small” Acts of Kindness
    • How To: Endoscopic Total Maxillectomy Without Facial Skin Incision
    • Science Communities Must Speak Out When Policies Threaten Health and Safety
    • Observation Most Cost-Effective in Addressing AECRS in Absence of Bacterial Infection

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939